Skip to main content
Equibles
ERAS logo

ERAS · Erasca, Inc.

Track ERAS — free

Use ERAS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about ERAS

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$18.38 +0.52 (+2.91%) At close · Aug 14
Market Cap
$6.43B
Shares
349.76M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.

Funds holding ERAS

229 fund positions
Fund Balance Value % of Fund Open
VANGUARD TOTAL STOCK MARKET INDEX FUND 8,309,645 $134,450,056 0.01%
T. Rowe Price Capital Appreciation Fund 6,954,600 $112,525,428 0.17%
State Street(R) SPDR(R) S&P(R) Biotech ETF 4,733,094 $76,581,461 1.03%
iShares Russell 2000 ETF 4,634,489 $74,986,032 0.10%
VANGUARD EXTENDED MARKET INDEX FUND 2,658,307 $43,011,407 0.05%
T. Rowe Price Small-Cap Stock Fund, Inc. 2,547,359 $41,216,269 0.51%
Select Biotechnology Portfolio 2,533,680 $32,532,451 0.62%
T. Rowe Price Small-Cap Value Fund, Inc. 1,796,208 $29,062,645 0.32%
iShares Russell 2000 Value ETF 1,626,806 $26,321,721 0.21%
JNL/T. Rowe Price Capital Appreciation Fund 1,463,400 $23,677,812 0.17%
iShares Biotechnology ETF 1,384,399 $22,399,576 0.28%
T. Rowe Price Institutional Small-Cap Stock Fund 1,322,713 $21,401,496 0.49%
T. Rowe Price Health Sciences Fund, Inc. 1,247,913 $20,191,232 0.19%
Fidelity Small Cap Index Fund 1,876,002 $19,979,421 0.06%
Victory Pioneer Select Mid Cap Growth Fund 1,332,535 $17,109,749 0.90%
Fidelity Extended Market Index Fund 1,233,143 $15,833,556 0.04%
Schwab U.S. Small-Cap ETF 1,147,686 $14,736,288 0.06%
VANGUARD RUSSELL 2000 INDEX FUND 974,477 $12,512,285 0.07%
PGIM Jennison Health Sciences Fund 877,992 $11,273,417 0.81%
VY(R) T. ROWE PRICE CAPITAL APPRECIATION PORTFOLIO 691,200 $11,183,616 0.17%
BlackRock Health Sciences Opportunities Portfolio 709,864 $9,114,654 0.15%
T. Rowe Price Capital Appreciation Equity ETF 546,605 $8,844,069 0.14%
Penn Series Flexibly Managed Fund 495,500 $8,017,190 0.17%
Fidelity Enhanced Small Cap ETF 481,306 $7,787,531 0.19%
iShares Micro-Cap ETF 478,234 $7,737,826 0.64%
AB Small Cap Growth Portfolio 672,758 $7,164,873 0.25%
AB DISCOVERY GROWTH FUND, INC. 636,882 $6,782,793 0.25%
VANGUARD HEALTH CARE INDEX FUND 510,022 $6,548,682 0.03%
ALGER SMALL CAP FOCUS FUND 604,243 $6,435,188 0.81%
Fidelity SAI Small-Mid Cap Momentum Index Fund 563,907 $6,005,610 0.14%
JPMorgan Small Cap Value Fund 369,269 $5,974,772 0.52%
Fidelity Total Market Index Fund 447,468 $5,745,489 0.00%
iShares Core S&P Total U.S. Stock Market ETF 311,436 $5,039,034 0.01%
Master Small Cap Index Series 308,257 $4,987,598 0.10%
Fidelity Series Total Market Index Fund 364,924 $4,685,624 0.00%
EQ/AB Small Cap Growth Portfolio 280,470 $4,538,005 0.24%
Schwab Small-Cap Index Fund 417,336 $4,444,628 0.06%
Dimensional U.S. Core Equity 2 ETF 402,637 $4,288,084 0.01%
Fidelity Small Cap Value Index Fund 234,863 $3,800,083 0.21%
Invesco Dorsey Wright SmallCap Momentum ETF 283,076 $3,634,696 0.87%
U.S. SMALL CAP PORTFOLIO 336,298 $3,581,574 0.02%
EQ/2000 Managed Volatility Portfolio 198,189 $3,206,698 0.09%
VANGUARD U.S. MOMENTUM FACTOR ETF 244,429 $3,138,468 0.17%
Direxion Daily S&P Biotech Bull 3X Shares 271,194 $2,888,216 0.56%
Dimensional U.S. Small Cap ETF 263,455 $2,805,796 0.02%
Small Cap Value Portfolio 171,803 $2,779,773 0.48%
VictoryShares US Small Mid Cap Value Momentum ETF 161,955 $2,620,432 0.19%
LVIP State Street Small-Cap Index Fund 141,400 $2,590,448 0.12%
BlackRock Health Sciences Term Trust 159,240 $2,576,503 0.25%
Fidelity Nasdaq Composite Index Fund 188,496 $2,420,289 0.01%
Showing 1–50 of 229 positions
Key facts CIK 1761918 CUSIP 29479A108 13F (30d) 248 filings 247 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)